Role of Serine arginine protein kinase 1 and Minichromosome maintenance protein 2 in predicting epithelial ovarian cancer response to treatment and prognosis.

Enas Elkholy Asmaa Gaber Abdou Alshimaa Mahmoud Alhanafy Tarek Hashem Reham Hassan Mohamed Shehata

Published in: Indian journal of cancer (2024)

SRPK1 is an unfavorable biomarker in EOC patients because of its association with aggressive histologic type, advanced International Federation of Gynecology and Obstetrics (FIGO) stage, and worse survival. SRPK1 could promote the proliferation of EOC by up-regulation of MCM2.

Keyphrases

protein kinase
end stage renal disease
chronic kidney disease
newly diagnosed
nitric oxide
signaling pathway
protein protein
small molecule
replacement therapy